Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma, New England Journal of Medicine, vol.359, issue.6, pp.613-639, 2008. ,
DOI : 10.1056/NEJMra0708875
Monoclonal Antibody Therapy with Rituximab for Acute Lymphoblastic Leukemia, Hematology/Oncology Clinics of North America, vol.23, issue.5, pp.949-71, 2009. ,
DOI : 10.1016/j.hoc.2009.07.005
Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways, Leukemia, vol.32, issue.1, pp.13-21, 2010. ,
DOI : 10.1016/j.cellsig.2009.03.009
The biology of VEGF and its receptors, Nature Medicine, vol.9, issue.6, pp.669-76, 2003. ,
DOI : 10.1038/nm0603-669
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules, Nature Reviews Clinical Oncology, vol.26, issue.9, pp.507-525, 2009. ,
DOI : 10.1038/nrclinonc.2009.110
Correlation between High Vascular Endothelial Growth Factor-A Serum Levels and Treatment Outcome in Patients with Standard-Risk Acute Lymphoblastic Leukemia: A Report from Children's Oncology Group Study CCG-1962, Clinical Cancer Research, vol.12, issue.23, pp.6978-84, 2006. ,
DOI : 10.1158/1078-0432.CCR-06-1140
Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas, Leukemia Research, vol.32, issue.9, pp.1424-1454, 2008. ,
DOI : 10.1016/j.leukres.2008.01.008
Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression, Laboratory Investigation, vol.103, issue.11, pp.1512-1521, 2004. ,
DOI : 10.1038/labinvest.3700145
Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats, Cancer Res, vol.62, issue.21, pp.6289-96, 2002. ,
Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains, Nature Cell Biology, vol.280, issue.2, pp.113-136, 2006. ,
DOI : 10.1083/jcb.70.3.608
Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohematopoietic differentiation, Blood, vol.73, issue.7, pp.1896-903, 1989. ,
The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines, International Journal of Cancer, vol.12, issue.10, pp.2438-2483, 2008. ,
DOI : 10.1002/ijc.23793
Targeting Vascular Endothelial Growth Factor for Relapsed and Refractory Adult Acute Myelogenous Leukemias: Therapy with Sequential 1-??-D-Arabinofuranosylcytosine, Mitoxantrone, and Bevacizumab, Clinical Cancer Research, vol.10, issue.11, pp.3577-85, 2004. ,
DOI : 10.1158/1078-0432.CCR-03-0627
Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab, Annals of Oncology, vol.19, issue.2, pp.396-403, 2008. ,
DOI : 10.1093/annonc/mdm579
Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma, Clinical Cancer Research, vol.15, issue.10, pp.3495-502, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-2407
Early Antiangiogenic Activity of Bevacizumab Evaluated by Computed Tomography Perfusion Scan in Patients with Advanced Hepatocellular Carcinoma, The Oncologist, vol.13, issue.2, pp.120-125, 2008. ,
DOI : 10.1634/theoncologist.2007-0174
Clinical translation of angiogenesis inhibitors, Nature Reviews Cancer, vol.17, issue.10, pp.727-766, 2002. ,
DOI : 10.1038/nrc905
Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies, Cancer Res, vol.65, issue.3, pp.671-80, 2005. ,
Tumor metastasis: mechanistic insights and clinical challenges, Nature Medicine, vol.96, issue.8, pp.895-904, 2006. ,
DOI : 10.1038/nm1469
Tumor cell/endothelial cell tight contact upregulates endothelial adhesion molecule expression mediated by NF??B: Differential role of the shear stress, Experimental Cell Research, vol.316, issue.4, pp.615-641, 2010. ,
DOI : 10.1016/j.yexcr.2009.11.015
Chemotherapeutic drugs and human tumor cells cytokine network, International Journal of Cancer, vol.67, issue.9, pp.2031-2071, 2008. ,
DOI : 10.1002/ijc.23732
Chemotherapy-induced tumor gene expression changes in human breast cancers, Pharmacogenetics and Genomics, vol.19, issue.3, pp.181-92, 2009. ,
DOI : 10.1097/FPC.0b013e32831ebb5d
VEGF Blockade Inhibits Lymphocyte Recruitment and Ameliorates Immune-Mediated Vascular Remodeling, Circulation Research, vol.107, issue.3, pp.408-425, 2010. ,
DOI : 10.1161/CIRCRESAHA.109.210963